Project aims to establish of tumor-on-chip platform in the laboratory to mimic treatment gradient, immune celltumour infiltration and to explore glioblastoma-immune cell interactions after they enter glioblastoma (GBM) tumour microenvironment (TME) inconditions, similar to those in the patients.

Project plan is devided into 2 work packages:

WP 1: Modelling human immune-tumour cell interactions using tumor-on-chip platform

WP2: Modelling combinational treatments in tumor-on-chip platform